Matches in SemOpenAlex for { <https://semopenalex.org/work/W154175522> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W154175522 endingPage "25" @default.
- W154175522 startingPage "213" @default.
- W154175522 abstract "Kinins are peptide hormones that exert pathophysiological as well as pronounced beneficial physiological effects, mainly by stimulation of bradykinin (BK) B(2) receptors. Owing to the strong proinflammatory properties of kinins resulting from vasodilation, plasma extravasation, activation of mast cells, fibroblasts and macrophages, stimulation of sensory neurons, and the release of nitric oxide, prostaglandins, leukotrienes and cytokines, kinins are believed to play an important role in a variety of inflammatory diseases and pain. Beneficial effects of BK B(2) receptor antagonists in perennial rhinitis, asthma and brain edema have already been shown in clinical trials. Recently, the potential therapeutic utility of BK B(2) receptor antagonists has been extended by the discovery of orally active, nonpeptide BK B(2) receptor antagonists and the identification of novel indications for their use. On the other hand, kinins also have been identified as potent antihypertensive and organ-protective peptides. They have been shown to have vasodilatory, antihypertrophic, antiaggregatory and fibrinolytic effects due to the BK B(2) receptor-mediated release of the autacoids nitric oxide, prostacyclin and tissue plasminogen activator. A recent finding is that kinins are also involved in ischemic preconditioning. Orally active, nonpeptide BK B(2) receptor agonists as potential novel therapeutic agents in cardiovascular medicine have also been identified. In conclusion, interaction with the BK B(2) receptor by either its blockade or its stimulation offers promising therapeutic approaches. BK B(2) receptor antagonists may prove to be useful in the treatment of asthma, rhinitis, arthritis, colitis, pancreatitis, sepsis, edema, tissue injury, pain and possibly infections, hepatorenal syndrome, Alzheimer's disease and lung cancer. BK B(2) receptor agonists have potential in the treatment of cardiovascular diseases like hypertension, cardiac hypertrophy, restenosis and myocardial infarction and diabetic disorders." @default.
- W154175522 created "2016-06-24" @default.
- W154175522 creator A5077659287 @default.
- W154175522 date "2000-05-01" @default.
- W154175522 modified "2023-09-25" @default.
- W154175522 title "Bradykinin B2 receptor as a potential therapeutic target." @default.
- W154175522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12937626" @default.
- W154175522 hasPublicationYear "2000" @default.
- W154175522 type Work @default.
- W154175522 sameAs 154175522 @default.
- W154175522 citedByCount "9" @default.
- W154175522 countsByYear W1541755222012 @default.
- W154175522 countsByYear W1541755222013 @default.
- W154175522 countsByYear W1541755222019 @default.
- W154175522 crossrefType "journal-article" @default.
- W154175522 hasAuthorship W154175522A5077659287 @default.
- W154175522 hasConcept C126322002 @default.
- W154175522 hasConcept C134018914 @default.
- W154175522 hasConcept C149588370 @default.
- W154175522 hasConcept C170493617 @default.
- W154175522 hasConcept C203014093 @default.
- W154175522 hasConcept C2776246183 @default.
- W154175522 hasConcept C2779540182 @default.
- W154175522 hasConcept C2779591629 @default.
- W154175522 hasConcept C2781128415 @default.
- W154175522 hasConcept C71924100 @default.
- W154175522 hasConcept C98274493 @default.
- W154175522 hasConceptScore W154175522C126322002 @default.
- W154175522 hasConceptScore W154175522C134018914 @default.
- W154175522 hasConceptScore W154175522C149588370 @default.
- W154175522 hasConceptScore W154175522C170493617 @default.
- W154175522 hasConceptScore W154175522C203014093 @default.
- W154175522 hasConceptScore W154175522C2776246183 @default.
- W154175522 hasConceptScore W154175522C2779540182 @default.
- W154175522 hasConceptScore W154175522C2779591629 @default.
- W154175522 hasConceptScore W154175522C2781128415 @default.
- W154175522 hasConceptScore W154175522C71924100 @default.
- W154175522 hasConceptScore W154175522C98274493 @default.
- W154175522 hasIssue "4" @default.
- W154175522 hasLocation W1541755221 @default.
- W154175522 hasOpenAccess W154175522 @default.
- W154175522 hasPrimaryLocation W1541755221 @default.
- W154175522 hasRelatedWork W1012109982 @default.
- W154175522 hasRelatedWork W154175522 @default.
- W154175522 hasRelatedWork W1819668906 @default.
- W154175522 hasRelatedWork W1967828668 @default.
- W154175522 hasRelatedWork W2017901771 @default.
- W154175522 hasRelatedWork W2088309420 @default.
- W154175522 hasRelatedWork W2095544786 @default.
- W154175522 hasRelatedWork W2411811845 @default.
- W154175522 hasRelatedWork W2418194944 @default.
- W154175522 hasRelatedWork W2462416979 @default.
- W154175522 hasVolume "13" @default.
- W154175522 isParatext "false" @default.
- W154175522 isRetracted "false" @default.
- W154175522 magId "154175522" @default.
- W154175522 workType "article" @default.